Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer’s disease: a systematic review

BACKGROUND: Neuroimaging-biomarkers of Mild Cognitive Impairment (MCI) allow an early diagnosis in preclinical stages of Alzheimer’s disease (AD). The goal in this paper was to review of biomarkers for Mild Cognitive Impairment (MCI) and Alzheimer’s disease (AD), with emphasis on neuroimaging biomar...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Geriatr
Hlavní autoři: Ruan, Qingwei, D’Onofrio, Grazia, Sancarlo, Daniele, Bao, Zhijun, Greco, Antonio, Yu, Zhuowei
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4869390/
https://ncbi.nlm.nih.gov/pubmed/27184250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12877-016-0281-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky